Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection

Background: The estimated economic cost of Clostridioides difficile infection (CDI) is $5.4 billion annually, primarily attributed to acute-care costs. We previously reported data from ECOSPOR III that SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing recur...

Full description

Saved in:
Bibliographic Details
Main Authors: Stuart Cohen (Author), Thomas Louie (Author), Charles Berenson (Author), Alpesh Amin (Author), David Lombardi (Author), Sissi Pham (Author), Shirley Huang (Author), Elaine Wang (Author), Brooke Hasson (Author), Barbara McGovern (Author), Lisa Von Moltke (Author)
Format: Book
Published: Cambridge University Press, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available